Adrien Rennesson profile page

Adrien Rennesson is the CEO and co-founder of Syntopia, a Paris-based biotech company developing next-generation microfluidic platforms and advanced 3D biological models for preclinical drug discovery. He holds a degree in bioengineering from ESPCI Paris and a master’s degree from HEC Paris. Rennesson began his career as a management consultant before moving into leadership roles focused on strategy, operations and business growth. At Syntopia, he leads corporate strategy, fundraising, financial and administrative management and business development, building the company’s foundations and scaling its operations. Rennesson is a laureate of the i-Lab Deeptech Prize and a recipient of the Sanofi iTech Awards, reflecting Syntopia’s innovative potential at the interface of biology and technology. His areas of expertise include entrepreneurship, strategic planning, fundraising, project leadership and scaling deeptech companies, with a strong focus on translating scientific breakthroughs into impactful drug discovery solutions.